Therefore, the changes in the expression levels of ESR1 and FOBS genes in liver cancer inhibited HALLMARK MYC TARGETS V2 pathway, while HALLMARK HEME METABOLISM, HALLMARK COAGULATION and HALLMARK UV RESPONSE_DN pathways were activated. The gene discussed is ESR1; the disease is liver cancer.